Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CMTT: Propranolol and Topiramate for Chronic Migraine
NCT00772031Phase 3Completed
- Start
- Oct 2008
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic migraine comparing Topiramate + Propranolol with Topiramate + Placebo (2 arms). Primary endpoint: Change in the Number of Moderate to Severe Headache Days at 6 months. Started Oct 2008; status: completed.
02
Drugs
propranolol
03
Conditions
chronic migraine
Beyond the preview
Go deeper on NCT00772031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00772031.